Energy metabolism of skeletal muscle containing cyclocreatine phosphate. Delay in onset of rigor mortis and decreased glycogenolysis in response to ischemia or epinephrine.
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D003401:Creatine / Q000031:analogs & derivatives / Q000494:pharmacology; D004734:Energy Metabolism / Q000187:drug effects*; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D006003:Glycogen / Q000378:metabolism*; D048289:Imidazolidines; D007511:Ischemia; D007700:Kinetics; D051379:Mice; D009132:Muscles / Q000098:blood supply / Q000378:metabolism* / Q000503:physiopathology; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000031:analogs & derivatives* / Q000378:metabolism; D012298:Rigor Mortis / Q000503:physiopathology*
D000227:Adenine Nucleotides; D048289:Imidazolidines; D010710:Phosphates; D010725:Phosphocreatine; C012487:phosphocyclocreatine; D006003:Glycogen; D003401:Creatine; D004837:Epinephrine